Perspective Therapeutics, Inc. Balance Sheet
CATX|10 years of annual SEC 10-K data (FY2013-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
Perspective Therapeutics, Inc. had $58M in total assets and $55M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $55.9M | $2.4M | $5.3M | $2.6M | $5.9M | $5.2M | $7.7M | $2.9M | $2.7M | $2.7M |
| Accounts Receivable | $1.4M | - | - | - | - | - | - | $1.0M | $913.0K | $923.8K |
| Inventory | $1.4M | $980.0K | $645.0K | $530.0K | $494.0K | $323.0K | $334.4K | $404.0K | $359.7K | $405.6K |
| Current Assets | $53.2M | $67.3M | $5.5M | $7.3M | $5.4M | $10.3M | $13.6M | $16.3M | $19.2M | $4.4M |
| PP&E (Net) | $371.0K | $2.0M | $1.7M | $1.6M | $1.3M | $1.1M | $576.7K | $574.8K | $1.0M | $1.7M |
| Goodwill | $0 | - | - | - | - | - | - | - | - | - |
| Total Assets | $58.1M | $70.4M | $8.7M | $9.4M | $7.5M | $12.3M | $18.1M | $23.0M | $26.5M | $7.1M |
| Current Liabilities | $3.1M | $1.8M | $1.6M | $1.1M | $1.8M | $1.1M | $1.1M | $1.1M | $1.2M | $792.9K |
| Shareholders' Equity | $54.6M | $7.7M | $5.0M | $10.6M | $16.4M | $20.8M | $24.0M | $5.4M | $5.8M | $5.8M |